Alexandr V. Zagrebelnyi

Alexandr V. Zagrebelnyi

Auto-generated profile, based on publicly available information

Alexandr V. Zagrebelnyi

National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2018 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
NKN. P. Kutishenko
N. P. Kutishenko
MLM. M. Lukyanov
M. M. Lukyanov
АЗА. В. Загребельный
А. В. Загребельный
NDN. A. Dmitrieva
N. A. Dmitrieva
СМС. Ю. Марцевич
С. Ю. Марцевич
Госпитальный регистр больных, перенесших острое нарушение мозгового кровообращения (РЕГИОН): портрет заболевшего и исходы стационарного этапа лечения

31 December 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
OKO. E. Karpov
O. E. Karpov
MLM. M. Lukyanov
M. M. Lukyanov
SMS. Yu. Martsevich
S. Yu. Martsevich
APAndrey Pulin
Andrey Pulin
СМС. Ю. Марцевич
С. Ю. Марцевич
Проспективный госпитальный регистр больных с предполагаемыми или подтвержденными коронавирусной инфекцией COVID-19 и внебольничной пневмонией (ТАРГЕТ-ВИП): характеристика включенных больных и оценка исходов стационарного этапа лечения

1 January 2013 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
SBSergey Boytsov
Sergey Boytsov
SYS. S. Yakushin
S. S. Yakushin
SMS. Yu. Martsevich
S. Yu. Martsevich
MLM. M. Lukyanov
M. M. Lukyanov
NNN. N. Nikulina
N. N. Nikulina
МKМ. S. Kharlap
М. S. Kharlap

1 November 2019 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
VVV. P. Voronina
V. P. Voronina
АЗА. В. Загребельный
А. В. Загребельный
YLYulia Lukina
Yulia Lukina
NKN. P. Kutishenko
N. P. Kutishenko
NDN. A. Dmitrieva
N. A. Dmitrieva
СМС. Ю. Марцевич
С. Ю. Марцевич
Особенности течения мозгового инсульта у больных сахарным диабетом по данным регистра РЕГИОН-М

13 July 2021 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
STS. N. Tolpygina
S. N. Tolpygina
MCM. I. Chernysheva
M. I. Chernysheva
AZA. V. Zagrebelny
A. V. Zagrebelny
VVV. P. Voronina
V. P. Voronina
NPN. E. Parsadanyan
N. E. Parsadanyan
Aim. Assess the two-year survival rate of patients who have undergone acute cerebral circulation disorder, depending on their commitment to visiting the district polyclinic before and after discharge from the hospital.Material and methods. The outpatient part of the REGION-M register included 684 patients attached to the Moscow City Polyclinic №64, discharged from the Moscow City Clinical Hospital n.a. F.I. Inozemtsev of from 01.01.2012 to 04.30.2017 with a confirmed diagnosis of acute cerebral circulation disorder (cerebral stroke / transient ischemic attack).Results. Of the entire cohort, 83.2% of patients and 84.2% after hospital discharge attended the clinic during the year before the development of reference acute cerebral circulation disorder. Patients who attended the clinic before and after the reference stroke were older, more likely to have diabetes, comorbid disease and disability. For 22 months of follow-up, mortality was 28.8% (197 out of 684 people). Among those who applied and did not apply to the clinic before the reference acute cerebral circulation disorder, the difference in mortality tended to be reliable (27.4% versus 35.7%, p <0.1), while mortality was almost twice as low among patients who applied to the clinic at least 1 time after discharge (25.7%) than among patients who did not apply after discharge - 45.4%, p<0.0001. When adjusting for sex and age (the relative risk of death for them was 1.009, 95% confidence interval 1.005-1.01 2, p<0.0001 ), the statistical validity of reducing the risk of death was maintained when patients were committed to visiting the clinic after discharge - the relative risk of death 0.366 (95% confidence interval 0.269-0.500, p<0.0001 ).Conclusion. Lower mortality among those who visited the district polyclinic after undergoing stroke confirms the important role of medical observation in the posthospital period. At the same time, there is a reserve in improving the long-term prognosis of the lives of patients who have suffered a cerebral stroke or transient ischemic attack, due to greater coverage of patients with medical supervision in the clinic.

3 November 2021 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
MLM. M. Loukianov
M. M. Loukianov
SMS. Yu. Martsevich
S. Yu. Martsevich
EAE. Yu. Andrenko
E. Yu. Andrenko
SYSergey S. Yakushin
Sergey S. Yakushin
AVA. N. Vorobiev
A. N. Vorobiev
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials and methods. 3169 patients with AF were enrolled in outpatient RECVASA (Ryazan), RECVASA AF-Yaroslavl registries and hospital RECVASA AF (Moscow, Kursk, Tula). 2497 (78.8%) registries of patients with AF had CAD and 703 (28.2%) of them had a previous myocardial infarction (MI).Results. There were 2,497 patients with a combination of AF and CAD (age was 72.2±9.9 years; 43.1% of men; CHA2DS2-VASc – 4.57±1.61 points; HAS-BLED – 1.60±0,75 points), and the group with AF without CAD included 672 patients (age was 66.0±12.3 years; 43.2% of men; CHA2DS2-VASc – 3.26±1.67 points; HAS-BLED – 1,11±0.74 points). Patients with CAD were on average 6.2 years older and had a higher risk of thromboembolic and hemorrhagic complications (p<0.05). 703 patients with a combination of AF and CAD had the previous myocardial infarction (MI; age was 72.3±9.5 years; 55.2% of men; CHA2DS2-VASc – 4.57±1.61; HAS-BLED – 1.65±0.76), and 1794 patients didn't have previous MI (age was 72.2±10.0 years; 38.4% of men; CHA2DS2-VASc – 4.30±1.50; HAS-BLED – 1.58±0.78). The proportion of men was 1.4 times higher among those with the previous MI. Patients with a combination of AF and CAD significantly more often (p <0.0001) than in the absence of CAD received a diagnosis of hypertension (93.8% and 78.6%), chronic heart failure (90.1% and 51.2%), diabetes mellitus (21.4% and 13.8%), chronic kidney disease (24.8% and 17.7%), as well as anemia (7.0% and 3.0%; p=0.001). Patients with and without the previous MI had the only significant difference in the form of a diabetes mellitus higher incidence having the previous MI (27% versus 19.2%, p=0.0008). The frequency of proper cardiovascular pharmacotherapy was insufficient, mainly in the presence of CAD (67.8%) than in its absence (74.5%), especially the prescription of anticoagulants (39.1% and 66.2%; p <0.0001), as well as in the presence of the previous MI (63.3%) than in its absence (74.3%). The presence of CAD and, in particular, the previous MI, was significantly associated with a higher risk of death (risk ratio [RR]=1.58; 95% confidence interval [CI] was 1.33-1.88; p <0.001 and RR=1.59; 95% CI was 1.33-1.90; p <0.001), as well as with a higher risk of developing a combined cardiovascular endpoint (RR=1.88; 95% CI was 1.17-3 , 00; p <0.001 and RR=1.75; 95% CI was 1.44-2.12; p<0.001, respectively).Conclusion. 78.8% of patients from AF registries in 5 regions of Russia were diagnosed with CAD, of which 28.2% had previously suffered myocardial infarction. Patients with a combination of AF and CAD more often than in the absence of CAD had hypertension, chronic heart failure, diabetes, chronic kidney disease and anemia. Patients with the previous MI had higher incidence of diabetes than those without the previous MI. The frequency of proper cardiovascular pharmacotherapy was insufficient, and to a greater extent in the presence of CAD and the previous MI than in their absence. All-cause mortality was recorded in patients with a combination of AF and CAD more often than in the absence of CAD. All-cause mortality and the incidence of nonfatal myocardial infarction were higher in patients with AF and the previous MI than in those without the previous MI. The presence of CAD and, in particular, the previous MI, was significantly associated with a higher risk of death, as well as a higher risk of developing a combined cardiovascular endpoint.